Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

Kyle B. Matchett · SciRah

Researcher profile · Semantic Scholar

Kyle B. Matchett

Share profile

Kyle B. Matchett — researcher profile on SciRah

h-index: 14
Works: 40
Citations: 635

Most-cited papers

BRCA1 DEFICIENCY EXACERBATES ESTROGEN INDUCED DNA DAMAGE AND GENOMIC INSTABILITY
K. Savage, Kyle B. Matchett, Eliana M. Barros, K. M. Cooper +16 more
2014Cancer Research115 citations Open access
Semantic Scholar
Nano-encapsulation of a novel anti-Ran-GTPase peptide for blockade of regulator of chromosome condensation 1 (RCC1) function in MDA-MB-231 breast cancer cells.
Yusuf A. Haggag, Kyle B. Matchett, E. Dakir, P. Buchanan +5 more
2017International journal of pharmaceutics57 citations Open access
Semantic Scholar
Ran GTPase in nuclear envelope formation and cancer metastasis.
Kyle B. Matchett, S. McFarlane, Sophie E. Hamilton, Yousef S A Eltuhamy +4 more
2014Advances in Experimental Medicine and Biology57 citations Open access
Semantic Scholar
Concise Reviews: Cancer Stem Cells: From Concept to Cure
Kyle B. Matchett, T. Lappin
2014Stem Cells42 citations
Semantic Scholar
Tibetan PHD2, an allele with loss-of-function properties
Daisheng Song, Bradleigh E. Navalsky, W. Guan, Cassandra Ingersoll +12 more
2020Proceedings of the National Academy of Sciences of the United States of America40 citations Open access
Semantic Scholar
Novel Ran-RCC1 Inhibitory Peptide-Loaded Nanoparticles Have Anti-Cancer Efficacy In Vitro and In Vivo
Yusuf A. Haggag, Kyle B. Matchett, R. Falconer, M. Isreb +4 more
2019Cancers39 citations Open access
Semantic Scholar
Advances in Precision Medicine: Tailoring Individualized Therapies
Kyle B. Matchett, N. Lynam-Lennon, R. Watson, James A. L. Brown
2017Cancers36 citations Open access
Semantic Scholar
Erythropoietin drives breast cancer progression by activation of its receptor EPOR
Ka-Kui Chan, Kyle B. Matchett, Jonathan A. Coulter, Hiu-Fung Yuen +14 more
2017OncoTarget36 citations Open access
Semantic Scholar
Ran GTPase promotes cancer progression via Met receptor-mediated downstream signaling
Hiu-Fung Yuen, Ka-Kui Chan, A. Platt-Higgins, E. Dakir +9 more
2016OncoTarget35 citations Open access
Semantic Scholar
Intradermal Delivery of a Near-Infrared Photosensitizer Using Dissolving Microneedle Arrays.
Iman Hamdan, I. Tekko, Kyle B. Matchett, L. Arnaut +3 more
2018Journal of Pharmacy and Science33 citations
Semantic Scholar
Low-dose salinomycin induces anti-leukemic responses in AML and MLL
Gary D. R. Roulston, Charlotte L. Burt, Laura M. J. Kettyle, Kyle B. Matchett +8 more
2016OncoTarget19 citations Open access
Semantic Scholar
Novel antibodies directed against the human erythropoietin receptor: creating a basis for clinical implementation
P. Maxwell, Florinda Meléndez-Rodríguez, Kyle B. Matchett, J. Aragonés +21 more
2015British Journal of Haematology19 citations Open access
Semantic Scholar
Formulating RALA/Au nanocomplexes to enhance nanoparticle internalisation efficiency, sensitising prostate tumour models to radiation treatment
Lindsey Bennie, Jie Feng, C. Emmerson, W. Hyland +3 more
2021Journal of Nanobiotechnology17 citations Open access
Semantic Scholar
Anti-Invasive and Anti-Proliferative Effects of shRNA-Loaded Poly(Lactide-Co-Glycolide) Nanoparticles Following RAN Silencing in MDA-MB231 Breast Cancer Cells
Ankur Sharma, P. McCarron, Kyle B. Matchett, S. Hawthorne +1 more
2018Pharmaceutical Research14 citations Open access
Semantic Scholar
Integrated analysis of the molecular action of Vorinostat identifies epi-sensitised targets for combination therapy
Jodie Hay, K. Lappin, F. Liberante, Laura M. J. Kettyle +3 more
2017OncoTarget11 citations Open access
Semantic Scholar
Molecular and clinicopathological markers of prognosis in breast cancer
D. Boyle, Clare M. McCourt, Kyle B. Matchett, M. Salto-Tellez
2013Expert Review of Molecular Diagnostics11 citations
Semantic Scholar
Big Data-Led Cancer Research, Application, and Insights.
James A. L. Brown, Tríona Ní Chonghaile, Kyle B. Matchett, N. Lynam-Lennon +1 more
2016Cancer Research10 citations Open access
Semantic Scholar
A compound combination screening approach with potential to identify new treatment options for paediatric acute myeloid leukaemia
K. Lappin, Lindsay Davis, Kyle B. Matchett, Y. Ge +2 more
2020Scientific Reports9 citations Open access
Semantic Scholar
Development and validation of Ran as a prognostic marker in stage I and stage II primary breast cancer.
M. El-Tanani, A. Platt-Higgins, Hamdi Nsairat, I. Matalka +10 more
2023Life Science8 citations Open access
Semantic Scholar
Protein deregulation associated with breast cancer metastasis.
Ka-Kui Chan, Kyle B. Matchett, P. McEnhill, E. Dakir +7 more
2015Cytokine & growth factor reviews8 citations Open access
Semantic Scholar
Exploring perceived support of postgraduate medical science research students
C. McEvoy, R. Hunter, Kyle B. Matchett, L. Carey +3 more
20176 citations Open access
Semantic Scholar
Multiplex Screening for Interacting Compounds in Paediatric Acute Myeloid Leukaemia
Lauren V. Cairns, K. Lappin, Alexander Mutch, Ahlam A. Ali +2 more
2021International Journal of Molecular Sciences4 citations Open access
Semantic Scholar
High-Throughput Screen Identification of Albendazole As a Novel Repurposed Drug in Acute Myeloid Leukaemia
Kyle B. Matchett, Ivan Grishagin, Laura M. J. Kettyle, C. Dowling +3 more
20173 citations
Semantic Scholar
Mebendazole: A candidate FDA approved drug for repurposing in leukaemia
Kyle B. Matchett, Ivan Grishagin, Laura M. J. Kettyle, G. Gavory +3 more
20162 citations
Semantic Scholar
Corrigendum to "Development and validation of Ran as a prognostic marker in stage I and stage II primary breast cancer" [Life Sci., 329 (2023) 121964].
M. El-Tanani, A. Platt-Higgins, Hamdi Nsairat, Ismail I. Matalka +10 more
2023Life Science1 citations
Semantic Scholar
Advancing Precision Medicine: Tailoring Personalized Therapies
Kyle B. Matchett, N. Lynam-Lennon, R. Watson, James A. L. Brown
2019The Road from Nanomedicine to Precision Medicine1 citations
Semantic Scholar
Anti-Invasive and Anti-Proliferative Effects of shRNA-Loaded Poly(Lactide-Co-Glycolide) Nanoparticles Following RAN Silencing in MDA-MB231 Breast Cancer Cells
Ankur Sharma, P. McCarron, Kyle B. Matchett, S. Hawthorne +1 more
2018Pharmaceutical Research1 citations Open access
Semantic Scholar
Abstract 260: Elucidating the roles of the alternatively spliced transcripts of Septin 9
Paula Cunnea, K. Borthwick, Kyle B. Matchett, Karla A. McKee +2 more
20101 citations
Semantic Scholar
Abstract A02: High-capacity drug screen identification of novel synergistic drug pairs with venetoclax in acute myeloid leukemia
Ruairidh Harrigan, Evangeline Johnston, Kyle B. Matchett, T. Bjourson
2023Blood Cancer Discovery0 citations
Semantic Scholar
PB1779: DEVELOPING NOVEL SYNERGISTIC DRUG COMBINATIONS WITH VENETOCLAX IN ACUTE MYELOID LEUKAEMIA
Ruairidh Harrigan, Evangeline Johnston, Kyle B. Matchett, Tony Bjourson
2022HemaSphere0 citations Open access
Semantic Scholar
Identifying Combination Therapies Targeting Apoptosis Pathways in Pediatric Acute Myeloid Leukemia (CAuSAL Study)
K. Lappin, Kyle B. Matchett, J. Blayney, K. Mills
2018Blood0 citations
Semantic Scholar
Big data-led cancer research, applications and insights
J. Al Brown, T. Chonghaile, Kyle B. Matchett, N. Lynam-Lennon +1 more
20180 citations
Semantic Scholar
Cutting oestrogen could lead to fewer women undergoing preventative mastectomy
Kyle B. Matchett
20140 citations
Semantic Scholar
Novel mechanisms of sensitivity and acquired resistance to HSP90 inhibition by ganetespib
S. Busacca, H. Pringle, E. Law, Laura O'Regan +6 more
20130 citations
Semantic Scholar
Sensitive and Specific Antibody Probes Directed Against The Erythropoietin Receptor – From Basic Studies To Clinical Implementation
Florinda Melendez, Kyle B. Matchett, J. Aragonés, Nathalie Ben-Califa +15 more
20130 citations
Semantic Scholar
Deregulated estrogen metabolism in BRCA1 deficient cells induces chromosomal instability.
Kyle B. Matchett, K. Savage, K. M. Cooper, Julia J. Gorski +5 more
20120 citations
Semantic Scholar
Abstract 5012: Regulation of splicing of SEPT9 in health and disease
Paula Cunnea, Kyle B. Matchett, P. Hall, H. Russell
20110 citations
Semantic Scholar
Regulation of splicing of SEPT9 in health and disease
Paula Cunnea, Kyle B. Matchett, P. Hall, H. Russell
20110 citations
Semantic Scholar
Differential expression of SEPT9 splice variants in malignant ovarian tumors and during the cell cycle
Kyle B. Matchett, K. Borthwick, J. Paul, Robert Brown +2 more
20080 citations
Semantic Scholar
a novel antiRanGTPase peptide for blockade
Yusuf A. Haggag, Kyle B. Matchett, Dakir El-Habib, Paul S. Buchanan +5 more
0 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

M. El-Tanani×9
Invite
M. El-Tanani — researcher profile on SciRah
K. Mills×8
Invite
K. Mills — researcher profile on SciRah
Ahmed M. Faheem×6
Invite
Ahmed M. Faheem — researcher profile on SciRah
P. McCarron×6
Invite
P. McCarron — researcher profile on SciRah

×5

Invite

P. Rudland — researcher profile on SciRah

M. El-Tanani×5

Invite

M. El-Tanani — researcher profile on SciRah

Invite

T. Lappin — researcher profile on SciRah

N. Lynam-Lennon×4

Invite

N. Lynam-Lennon — researcher profile on SciRah

A. Platt-Higgins×4

Invite

A. Platt-Higgins — researcher profile on SciRah

Laura M. J. Kettyle×4

Invite

Laura M. J. Kettyle — researcher profile on SciRah

Invite

A. Thompson — researcher profile on SciRah

Invite

K. Lappin — researcher profile on SciRah